Stock & Company Details
Enliven Therapeutics Inc $ELVN
Price:
N/A
N/A
73M
$3.3B
52 Week High:
N/A
10 Day Average Volume:
N/A
-27.03
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ELVN technical indicators
Latest Enliven Therapeutics Inc (ELVN) indicator readings as of 2026-10-29.
ELVN's 14-day RSI is 54.5, in neutral territory. At $45.08 it is trading 5.7% above its 200-day moving average of $42.64, and below its 50-day average of $49.00. Price sits near the upper Bollinger Band ($36.93 to $46.51). ADX reads 35.5, indicating a trending market.
Overview
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.
Finance Bot
Ask your questions
Start by typing a question below.
